SKI Market

A+| A| A-|

Indian Indices

Sensex

75,237.99 -160.73
( -0.21%)

Global Indices

Nasdaq

49,543.85 -540.61
(-1.08%)

Dow Jones

7,428.26 -93.98
(-1.25%)

Hang Seng

61,141.50 -1,512.55
(-2.41%)

Nikkei 225

10,172.40 -200.53
(-1.93%)

Forex

USD-INR

95.71 0.07
(0.07%)

EUR-INR

111.93 -0.13
(-0.12%)

GBP-INR

129.01 -0.31
(-0.24%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alka Securities Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

532166

INE921C01031

0.0104023

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

8.54

EPS(TTM)

Face Value()

Div & Yield %

0.01

Back

Tatva Chintan Pharma Chem reports consolidated net profit of Rs 9.92 crore in the September 2025 quarter

Oct 31,2025

Net profit of Tatva Chintan Pharma Chem reported to Rs 9.92 crore in the quarter ended September 2025 as against net loss of Rs 0.66 crore during the previous quarter ended September 2024. Sales rose 47.95% to Rs 123.52 crore in the quarter ended September 2025 as against Rs 83.49 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	123.52	83.49	48
OPM %	17.98	6.68	-
PBDT	22.72	5.79	292
PBT	13.66	-1.02	LP
NP	9.92	-0.66	LP

75,237.99 -160.73 ( -0.21%)

49,543.85 -540.61 (-1.08%)

7,428.26 -93.98 (-1.25%)

61,141.50 -1,512.55 (-2.41%)

10,172.40 -200.53 (-1.93%)

95.71 0.07 (0.07%)

111.93 -0.13 (-0.12%)

129.01 -0.31 (-0.24%)

0.61 0.00 (-0.09%)